EPG Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,390
Closed -$533K 433
2023
Q2
$533K Buy
4,390
+232
+6% +$30.9K 0.16% 144
2023
Q1
$639K Buy
+4,158
New +$686K 0.2% 115
2020
Q2
Sell
-900
Closed -$27K 536
2020
Q1
$27K Buy
+900
New +$20.7K 0.02% 354

Other funds holding MRNA

EPG Wealth Management's MRNA Position: Q3 2023 in Review

EPG Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,390 shares — an estimated $533K sold.

EPG Wealth Management first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $639K in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • EPG Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • EPG Wealth Management sold 4,390 Moderna shares in Q3 2023, an estimated $533K.
  • EPG Wealth Management first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
  • EPG Wealth Management's Moderna position peaked at $639K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on EPG Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.